Compugen Ltd (NAS:CGEN)
$ 1.77 -0.03 (-1.66%) Market Cap: 152.85 Mil Enterprise Value: 63.87 Mil PE Ratio: 0 PB Ratio: 2.60 GF Score: 54/100

Q3 2022 Compugen Ltd Earnings Call Transcript

Nov 14, 2022 / 01:30PM GMT
Release Date Price: $0.8347 (-9.27%)
Operator

Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's Third Quarter 2022 Results Conference Call. (Operator Instructions) An audio webcast of this call is available in the Investors section of Compugen's website, www.cgen.com. As a reminder, today's call is being recorded.

I would now like to introduce Yvonne Naughton, Head of Investor Relations and Corporate Communications. Yvonne, please go ahead.

Yvonne Naughton
Compugen Ltd. - Head of IR & Corporate Communications

Thank you, Jamie, and thank you all for joining us on the call today. Joining me from Compugen are Dr. Cohen-Dayag, President and Chief Executive Officer; Dr. Henry Adewoye, Chief Medical Officer; Dr. Eran Ophir, Senior Vice President Research and Drug Discovery; and Alberto Sessa, Chief Financial Officer.

Before we begin, we would like to remind you that during this call, the company may make projections or forward-looking statements regarding future events, business outlook, development

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot